New Republic Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
New Republic Capital's VRTX Position: Q2 2026 in Review
New Republic Capital increased its Vertex Pharmaceuticals (VRTX) stake by 18% in Q2 2026, buying an estimated $42.5K and bringing the position to 628 shares worth $312K. The position accounts for 0.07% of the portfolio, ranked #208.
New Republic Capital first reported a position in VRTX in Q2 2024 and has held it in 4 quarters since. The position peaked at $374K in Q4 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- New Republic Capital held 628 shares of Vertex Pharmaceuticals worth $312K as of Q2 2026.
- New Republic Capital bought 96 Vertex Pharmaceuticals shares in Q2 2026, an estimated $42.5K.
- Vertex Pharmaceuticals made up 0.07% of New Republic Capital's portfolio in Q2 2026, its #208 holding.
- New Republic Capital first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
- New Republic Capital's Vertex Pharmaceuticals position peaked at $374K in Q4 2025.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.